Dr Moore studied medicine in Edinburgh before moving to Gloucestershire to work as a GP principal. He has an interest in cardiology and cardiovascular disease, particularly those aspects that are relevant to primary care and contributes regularly to related educational events across the UK. He is President of the primary care cardiovascular society.

Dr Moore was involved in the development of the Primary Care based Gloucestershire Heart Failure service where he continues to work as a GPwSI.

He continues to represent Primary Care in the cardiovascular arena at both a local and national level. He has provided cardiovascular clinical support to local commissioning organisations for over ten years and remains actively involved in commissioning local cardiology services chairing the Circulatory Clinical Programme Group for Gloucestershire Clinical Commissioning Group (CCG). He was Clinical Lead for the community based West of England AHSN Stroke Prevention in AF project: Don’t wait to anticoagulate.

Dr Moore previously served on the board of the British Society for Heart Failure and was a member of the NICE Chronic Heart Failure Guideline committee (2018). He currently sits on the National Heart Failure Audit Steering group.

Helen is the National Speciality Adviser for CVD Prevention at NHSE&I and is working on delivery of the CVD ambitions for AF, Blood Pressure and Cholesterol in line with the Long-Term Plan. Helen has worked as a CVD specialist for more than 25 years in hospital, community, and primary care settings. She has led on the development and implementation of consensus evidence-based CVD guidance for use across South London covering a population of 3.6million and supported local practitioners through education and training, guideline implementation, clinical audit, service development and provision of virtual or face to face clinics. She was clinical adviser to the national AF AHSN programme and developed the pharmacist-led virtual clinic model to optimise uptake of anticoagulation in AF, which is now being spread nationally through the NHSE AF demonstrator programme. She is currently working at UCLP on the development and implementation of long-term conditions packages designed to support primary care in the post COVID-19 environment.

Dr Dermot Neely is former Head of the Lipid Clinic, Royal Victoria Infirmary, Newcastle and Director of Supra-Regional Assay Services for Lipids and Cardiovascular Biomarkers in the Integrated Laboratory Medicine Directorate, Newcastle upon Tyne Hospitals NHS Foundation Trust. He was an expert adviser on the NICE Lipid Modification Guidelines in 2008 (CG67) and member of the Guideline Development Group for the CG181 guideline in 2012–14. Now retired from clinical practice, he is currently Specialist Adviser on Lipids to the Academic Health Sciences Network for North East and North Cumbria, a member of the AAC Rapid Uptake Products Working Group on PCSK9 inhibitors and sits on the NHSE Specialist Advisory Group on Familial Hypercholesterolaemia. Dr Neely is a founder Trustee of HEART UK and co-chair of the HEART UK Familial Hypercholesterolaemia Intelligence Network (FHIN).

Beverley is an Advanced Nurse Practitioner in general practice in Gloucestershire and a PCN Nurse Coordinator in Hereford. She is also Editor in Chief of Practice Nurse journal. She qualified as an RGN at St George’s Hospital London and gained a BSc in Professional Nursing Studies after completing 2 years of an advanced clinical practice MSc at Wolverhampton University. She is an Independent Nurse Prescriber and holds an MSc in Respiratory Care and an MA in Medical Ethics and Law.

Beverley’s other qualifications include a Post Graduate Award in Diabetes Therapeutics from Warwick University.

Beverley has extensive educational experience developing modules in diabetes and CVD for an Open University-affiliated organisation and is an Expert Witness for a clinical negligence company. She has been a Queen’s Nurse since 2015, a title which is given to nurses who have demonstrated a high level of commitment to patient care and nursing practice.

Beverley is a council member for the Primary Care Cardiovascular Society and has worked on the Implementation Steering Group of Public Health England’s CVDPREVENT project and Oxford AHSN’s ‘Prevention of CVD during the pandemic’ guidance. She has also been a Visiting Lecturer in behaviour change at Imperial College London for the MSc in Preventive Cardiology.

Professor Ahmet Fuat has been a GP in Darlington, Co.Durham for 33 years. He has been a GPSI Cardiology for 20 years having undertaken a Postgraduate Diploma in Cardiol-ogy at Bradford University graduating with distinction. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 17 years ago with local colleagues. His PhD by research in heart failure diagnosis and management including work on natriuretic pep-tides generated several publications that have informed guidelines and led to the award of an Hon-orary Professorial Chair at Durham University.

He holds various roles in CVD and research including the Past President of the new Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming, CVD Clinical Adviser to the RCGP, CVD and Research Leads for Darlington Primary Care Network (PCN) and Federation, As-sociate Lead for Industry Research at North East and North Cumbria NIHR CRN. He has recently been elected onto the newly formed Darlington PCN Governing body as a GP member, CVD, Research Leads and Chair.

He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular Jour-nals and a peer reviewer for most high impact Cardiovascular journals and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh.